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Gli3aly (HPE) is a common birth defect characterized by the absence of midline cells
from brain, facial, and oral structures. To understand the pathoetiology of HPE, we investigated the
involvement of mammalian prechordal plate (PrCP) cells in HPE pathogenesis and the requirement of the
secreted protein sonic hedgehog (Shh) in PrCP development. We show using rat PrCP lesion experiments and
DiI labeling that PrCP cells are essential for midline development of the forebrain, foregut endoderm, and
ventral cranial mesoderm in mammals. We demonstrate that PrCP cells do not develop into ventral cranial
mesoderm in Shh−/− embryos. Using Shh−/− and chimeric embryos we show that Shh signal is required for the
maintenance of PrCP cells in a non-cell autonomous manner. In addition, the hedgehog (HH)-responding
cells that normally appear during PrCP development to contribute to midline tissues, do not develop in the
absence of Shh signaling. This suggests that Shh protein secreted from PrCP cells induces the differentiation
of HH-responding cells into midline cells. In the present study, we show that the maintenance of a viable
population of PrCP cells by Shh signal is an essential process in development of the midline of the brain and
craniofacial structures. These ﬁndings provide new insight into the mechanism underlying HPE
pathoetiology during dynamic brain and craniofacial morphogenesis.
© 2008 Elsevier Inc. All rights reserved.IntroductionHoloprosencephaly (HPE) is a common birth defect characterized
by the absence of midline structures in the brain, facial, and oral
structures. In humans, it is estimated that HPE affects one in every
10,000–20,000 live births. Since many pregnancies with a fetus
diagnosed with HPE end in miscarriage, the frequency of HPE among
all pregnanciesmay be as high as 1 in 250 (Muenke and Beachy, 2000).
HPE is associated with environmental factors and genetic causes,
although HPE pathoetiology is not well characterized. Mutations in
human DKK1 (Roessler et al., 2000), GLI2 (Roessler et al., 2003), SONIC
HEDGEHOG (SHH) (Belloni et al., 1996; Roessler et al., 1996), SIX3
(Wallis et al., 1999), PTCH1 (Ming et al., 2002), TDGF1 (de la Cruz et al.,
2002), TGIF (Gripp et al., 2000) and ZIC2 (Brown et al., 1998, 2001)
genes are identiﬁed as genetic causes of human HPE, while fetaltoyama).
arch, 1000 E. 50th St., Kansas
l rights reserved.alcohol exposure and maternal diabetes are well known environ-
mental causes (Cohen and Shiota, 2002).
Prechordal plate (PrCP) cells are a potential target of environ-
mental and genetic causes of HPE. PrCP cells form the most anterior
section of anterior-streak derived axial mesendoderm, which is
distinguished from rest of axial mesendoderm by goosecoid-1 gene
expression (Belo et al., 1998). PrCP cells migrate out from the ante-
rior primitive streak and locate beneath the anterior neural plate
around E7.5–7.75. PrCP cells appear to be the essential organizing
center for midline speciﬁcation of brain, facial, and oral structures,
because severe HPE is caused by removal of the PrCP cells from
amphibian and chick embryos (Adelman, 1936; Li et al., 1997; Pera
and Kessel, 1997; Schneider and Mercola, 1999). The development
of chick PrCP cells is well characterized (Seifert et al., 1993). Using
light and electronmicroscopy Seifert et al. (1993) showed that the
chick PrCP develops into mesoderm tissue distributed between
foregut endoderm and neuroepithelium. Seifert et al. referred to
these PrCP cells as axially located endoderm to distinguish this
tissue from the prechordal mesoderm arising from PrCP cells via
epithelio-mesenchymal transformation. The development of chick
PrCP cells into prechordal mesoderm is conserved during mammalian
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(Meier and Tam, 1982; Sulik and Johnston, 1982; Sulik et al., 1994),
rabbit (Aasar, 1931; Viebahn, 1995, 1999) and human embryos
(Müller and O'Rahilly, 2003). Noteably, Müller and O'Rahilly (2003)
reveal that human notochordal and prechordal plates are continuous,
but can be distinguished histologically, during human embryonic
stage 8–10). Chick prechordal mesoderm is required for speciﬁcation
of ventral forebrain and this process is mediated by Shh and Bmp
signaling (Dale et al., 1997). Investigation of the developmental basis
of HPE pathogenesis requires identiﬁcation of the role of mam-
malian PrCP cells in midline development and the underlying molec-
ular mechanism.
Shh protein expression may be directly required for the develop-
ment of PrCP cells. Shh, a member of the hedgehog (Hh) family of
secreted signaling proteins, is required for induction of ventral
midline cell types including those of the ﬂoor plate and motor
neurons (Martí et al., 1995; Porter et al., 1995; Roelink et al., 1995;
Chiang et al., 1996). Mutations in human SHH are the most frequent
cause of autosomal-dominant inherited HPE. This is supported by the
ﬁnding that Shh−/− mouse embryos exhibit severe HPE (Belloni et al.,
1996; Chiang et al., 1996; Roessler et al., 1996; Nanni et al., 1999).
During early embryogenesis, the Shh protein is expressed in the axial
mesendoderm, which is the origin of the notochordal plate and PrCP
cells. The HPE phenotype of Shh−/− mouse embryos suggests an
important role for the Shh protein secreted from PrCP cells in the
induction of midline cells of the brain and craniofacial structures,
which is consistent with observations in chick embryos (Chiang et al.,
1996; Dale et al., 1997). Although mutations in Shh gene are identiﬁed
as genetic causes of HPE in humans andmice, the requirement for SHH
in the development of mouse PrCP cells is unclear.
Shh signal may be required for the maintenance of a viable
population of PrCP cells. We recently showed that transient fetal
ethanol exposure at E7.0 reduces Shh expression and induces
excessive apoptosis speciﬁcally in anterior PrCP cells that results in
HPE (Aoto et al., 2008). Fetal alcohol exposure is a well known
environmental risk causing a range of birth defects, including HPE,
collectively referred to as fetal alcohol syndrome (Sulik et al., 1981;
Cohen and Shiota 2002). Our ﬁndings suggest that ethanol inhibits
Shh protein expression in anterior PrCP cells that results in apoptosis
as a critical onset of HPE. Based on these observations, we hypothesize
that Shh signal is required for PrCP cell survival during early mouse
embryogenesis. This hypothesis is supported by ﬁndings that Shh
protein functions as a survival factor in other developmental systems,
including neural crest cells (Ahlgren and Bronner-Fraser, 1999; Brito
et al., 2006; Calloni et al., 2007), somites (Krüger et al., 2001), and
cerebellum (Kenney et al., 2004).
In the present study, we investigated the developmental basis of
mammalian HPE pathoetiology. We initially investigated the role of
mammalian PrCP cells in midline development by generating PrCP
lesions and examining the fate map of the PrCP cells during normal
brain and craniofacial development.We then examined the role of Shh
signal in PrCP cell development using Shh−/− and chimeric embryos.
We also assessed the requirement of PrCP cells in midline develop-
ment by examining Shh;Gli3 double mutants phenotype and the
contribution of HH-responding cells to the midline tissue during the
development of PrCP cells. The results of this study provide evidence
to conﬁrm a novel function for Shh signaling in maintaining a viable
population of PrCP cells during dynamic morphogenesis of the mouse
brain and craniofacial development.
Materials and methods
Mutant mice
Mutant mice for Gli3 (Gli3Xt-J), Shh (Shhtm1Amc), and Ptch1
(Ptch1tm1Mps) were maintained on a CD1 background, and geno-typing of mutants was performed as described (Goodrich et al., 1997;
St-Jacques et al., 1998; Maynard et al., 2002). The Gli1-CreERT2
(Gli1tm3(cre/ESR1)Alj) mouse line was used for the lineage analysis
of HH-responding tissues (Ahn and Joyner, 2004, 2005). To maintain
their genetic background on a CD1, we backcrossed heterozygous
carriers to CD1 animals more than 10 generations. In addition we
maintained all the mutant animals by continuous backcross of
heterozygous carriers to CD1 animals.
Whole embryo culture lesion experiments
The effect of removing PrCP cells on midline development was
examined in cultured whole embryos. Whole embryo cultures were
prepared as described previously (Cockroft, 1990; Matsuo et al., 1993;
Lee et al., 1995). Lesion experiments were performed using Sprague–
Dawley rat embryos at the 0 somite (0s) stage because their large size
facilitates PrCP cell visualization and they remain viable for more than
78 h in culture. Rat embryos were surgically removed from
anesthetized mothers on Day 9.5 (plug day=Day 0; 0 somite stage,
corresponding to Day 7.75 in the mouse), placed under an optical
microscope, and dissected from the uterus with the placenta and
embryonic membranes intact. Intact embryos were immediately
processed for removal of PrCP cells. The endoderm cell layer
containing the PrCP cells was removed with a tungsten needle.
Some embryos were processed for SEM observation to conﬁrm
complete surgical removal of the PrCP cell layer. Embryos were
transferred to culture within 1 h of removal of the PrCP cell layer,
incubated for 60 h, then observed by SEM to characterize facial
structures. Control embryos with an intact PrCP cell layer were
processed in parallel. Each embryo was placed in a 15-ml culture
bottle containing 2.5 ml of culture media comprised of 100% rat serum
with 2 mg/ml glucose. The culture bottles were attached to a rotator
drum and rotated at 20 rpm at 38 °C while being continuously
supplied with a suitable concentration of O2 (5 or 20%) and CO2 (5%)
balanced with N.
Cell-lineage analysis using DiI labeling
We labeled the PrCP cells of zero-somite (0s) mouse (E7.75) and rat
(E9.5) embryos with DiI and/or DiO (Molecular Probes, Eugene, OR,
USA). Dye saturated with 100% dimethylformamide was diluted
30-fold (DiI) and 10-fold (DiO) in 0.3 M sucrose and spotted onto
the PrCP cell layer. In case of the focal labeling, the size of the spot was
approximately 50 μm in diameter. The position of each dye spot was
photographically documented immediately. The embryos were intro-
duced into 100% rat serum containing 2 mg/ml glucose as described
above. After 24 h or 60 h in culture (at the 12s or 30s stage), the
distribution of DiI and/or DiO labeled cells was identiﬁed in serial
sections of the cultured embryos. The lateral view of distribution of
DiI labeled cells in whole-mount rat embryos was also photographi-
cally documented immediately after cutting the cultured embryo at
the midline.
Histology
Whole-mount and section in situ hybridization was performed as
described previously (Motoyama et al., 1998) using non-radioactive
digoxigenin-labeled probes for Fgf8 (Shimamura et al., 1995), Gli1 (Hui
et al., 1994), Gsc (Blum et al., 1992), Hesx1 (Hermesz et al., 2003),
Nkx2.1 (Shimamura et al., 1995), Noggin (McMahon et al., 1998), Pax2
(Nornes et al., 1990), Pax7 (Jostes et al., 1990), Pax9 (Peters et al., 1998),
Shh (Echelard et al., 1993), Six3 (Oliver et al., 1995) and T (Herrmann,
1991). Whole-mount immunohistochemistry for detection of FOXA2
was performed as described previously (Motoyama et al., 1998). The
following primary antibodies were used: mouse anti-SHH (1:50
dilution; Developmental studies hybridoma bank, Iowa, USA),
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USA) rabbit anti-FOXA2 (1:2000 dilution; gift of H. Sasaki) and anti-
single-stranded DNA antibody (1:100 dilution; Dako Cytomation,
Kyoto, Japan). All sections were counterstained with 4′,6-diamidino-
2-phenylindole (DAPI; Sigma, St. Louis, MO, USA) for nuclear staining.
β-Galactosidase activity was detected using previously described
methods (Ding et al., 1998). X-Gal-stained embryos were postﬁxed
with 4% PFA at 4 °C overnight, embedded in parafﬁn, and 7 μm serial
sections were counterstained with Eosin.
Chimera analyses
We crossed Shh heterozygous carriers to B5/EGFP transgenic mice
(Hadjantonakis et al., 1998) to obtain Shh+/−;B5/EGFP mice. They were
maintained by continuous backcross of heterozygous carriers to CD1
animals more than 10 generations. Shh null ES cell lines expressing
EGFP were established from Shh−/−;B5/EGFP embryos (Hogan et al.,
1994). The Shh+/+;B5/EGFP ES cells were established from the
littermates of Shh−/−;B5/EGFP embryos as control ES cells. We isolated
blastocysts from CD1 mice for the chimera generation. We generated
chimeric embryos from three independently established Shh−/−;
B5/EGFP ES cell lines and assessed the contribution of EGFP-positiveFig. 1. Removal of the prechordal plate (PrCP) induces HPE in rat embryos. Shh is expressed th
localized to PrCP cells (B). The black bracket delineates the position of the PrCP (B). Scann
embryos at the 0s stage. The white bracket delineates the position of the lesion (D). Photomi
(F, G). Frontal view of Shh−/− embryos at the 30s stage (H). Note that 8 PrCP-lesioned embryos
embryos (H) (n=18). In situ hybridization of whole-mount rat embryos at 30s stage reveals S
views of whole-mount embryos show Shh and Nkx2.1 expression, respectively (I–L). Note th
and diencephalons (red arrowhead in I and K) have disappeared in PrCP-lesioned embryos
telencephalon; mb, midbrain. Scale bars, 100 μm (A–D), 200 μm (E–H).Shh−/− cells to the host tissue in 1, 2, 3s (E8.0) and E10.5 stage embryos.
We examined the contribution of EGFP-positive wild-type ES cells as a
control. All mutant ES cell lines behaved similarly in the chimeric
embryos (data not shown). Data are presented as mean±s.e.m. The
student t-test was used for statistical analysis. Pb0.05 was considered
signiﬁcant.
Cell-lineage analysis of HH-responding tissues
Tissue lineage analyses were conducted by analyzing Gli1-CreERT2;
R26R mice (Li et al., 2000; Ahn and Joyner, 2004, 2005). The Gli1-
CreERT2 mice were crossed with R26R-LacZ indicator mice (Soriano,
1999) to obtain Gli1-CreERT2/+;R26R/R26R males, which were subse-
quently crossed with ICR females. Noon of the day of a vaginal plug
was designated as E0.5. A 20 mg/ml stock solution of tamoxifen
(T-5648, Sigma) was prepared in corn oil. Two milligrams of
tamoxifen per 40 g body weight was administered to the pregnant
ICR mouse females using oral gavage at E8.5, 9.5 and 11.5 to label the
HH-responding cells. Mouse embryos at E14.5 were processed for
whole-mount or section X-Gal staining. No overt teratologic effects
were observed after tamoxifen administration at E8.5 of pregnancy
under these conditions (data not shown).roughout the axial mesendoderm, notochordal and prechordal plate (A), whereas Gsc is
ing electron micrographs show frontal views of control (C) and PrCP-lesioned (D) rat
crographs show frontal views of control (E) and PrCP-lesioned embryos at the 30s stage
showmild (F) and 9 show severe HPE (G), which is similar to the level observed in Shh−/−
hh (I, J) and Nkx2.1 (K, L) mRNA in control (I, K) and PrCP-lesioned embryos (J, L). Lateral
at Shh and Nkx2.1 expression in the medial ganglionic eminence (red arrow in I and K)
(J, L), while Shh expression in the ventral midbrain is not affected (black arrow in J). te,
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Lesion of rat PrCP results in HPE
Lesion of the PrCP results in severemidline defects (e.g., cyclops) in
amphibians and chicks embryos similar to those observed in humanFig. 2. The development of PrCP into the midline of foregut endoderm, presumptive oral end
labeling. (A) As shown in the frontal views of rat embryos anterior (A) and posterior (B) axial
the 30s stage, the distribution of labeled PrCP-derived cells was examined in lateral views of w
cells derived from anterior axial mesendoderm are in the beneath the diencephalon (arrow
(arrows in B). As shown in the frontal views of wild-type mouse embryos axial mesendod
positions along the anterior–posterior axis of the axial mesendoderm (domains I–VII, C). Ima
in C). At the 12s stage, the distribution of labeled PrCP-derived cells was examined in lat
(yellow arrows in C, I–VII-c). Lines in the panels (C, I–VII-b) indicate the position of secti
midline of ventral foregut endoderm and oral endoderm, while those from domain IV–VI d
to the heart tissue (C, II-c). Cells from domain VII developed into the notochord and dors
craniofacial development. DiI-positive cells in cultured 12s embryos (D–G) were examined b
3, G-1-3). Lines in the panels (D–G) indicate the position of sections shown in the panel
diencephalon (D-1, 2) but not in the notochord (E-1, 2), while those from domain Vwere obse
in F-1, 2, G-1). (H, I) Summary of cell-lineage tracing analysis via DiI/DiO labeling. (H) Label
view of a mouse embryo at E7.75. A photomicrograph of the lateral view of cultured 12s emb
spots relative to the anterior endoderm (AE in H) (domain I). as, aortic sac; di, diencephalons
mes, mesencephalon; n, notochord; ov, optic vesicle; refd, rostral extremity of foregut diverHPE (Adelman, 1936; Li et al., 1997; Pera and Kessel, 1997; Schneider
and Mercola, 1999). To examine whether lesion of mammalian PrCP
cells also triggers HPE, we surgically removed the endoderm cell layer,
including PrCP cell layer, from 0s rat embryos and assessed brain and
facial development (Figs.1C, D). The location and size of PrCP cells was
estimated by the expression of Shh and Goosecoid (Gsc) mRNA in 0oderm, and ventral cranial mesoderm shown by cell-lineage tracing analysis via DiI/DiO
mesendoderm at 0s stage (E9.5) were labeled by DiI (bracket in the left panel of A, B). At
hole-mount cultured embryos (right panel of A, B). Note that majority of the DiI labeled
s in A), while those from posterior axial mesendoderm were observed in the notochord
erm cells were labeled at the 0s stage (E7.75) by placing spots of DiI/DiO at different
ges show axial mesendoderm labeling within domain I, II, IV, V, and VII (yellow arrows
eral views of cultured embryos (yellow arrows in C, I–VII-b) and on coronal sections
ons shown in the left panels (C, I–VII-c). Cells from domains I–IV developed into the
eveloped into ventral cranial mesoderm. Some cells from domain I and II contributed
al foregut (C, VII-c). (D–G) Contribution of the PrCP cells from domain IV and V to the
y immunohistochemistry using anti-NKX2.1 (D-1-3, F-1-3) and anti-SHH antibody (E-1-
s (D-1–G-3). Note that the DiI labeled cells from domain IV were in the beneath the
rved both in the notochord (F-2, G-2) andmesoderm beneath the diencephalon (arrows
ing positions are indicated as domains I–VII on the photomicrograph showing a frontal
ryos showing the distribution of PrCP-derived cells. Anterior–posterior positions of DiI
; fba, ﬁrst branchial arch; fd, foregut diverticular; md, mandibular; me, metencephalon;
ticulum; te, telencephalon. Scale bar, 100 μm.
Table 1
Distribution of Dil labeled cells derived from mouse prechordal plate at E7.75
Labeling
position
# of
embryos
Distribution of labeled cells
Distance from
AE (μm)
(n) Ventral
foregut
Oral
endoderm
Ventral cranial
mesoderm
Dorsal
foregut
Notochord
0 4 4 0 0 0 0
I (++) 4
(+) 0
0–50 4 2 2 0 0 0
II (++) 2 0
(+) 0 2
50–100 6 1 3 2 0 0
III (++) 0 2 0
(+) 1 1 2
100–150 16 0 8 8 0 0
IV (++) 6 3
(+) 2 5
150–200 11 0 2 7 1 1
V (++) 0 5 0 0
(+) 2 2 1 1
200–250 11 0 0 5 3 3
VI (++) 3 0 0
(+) 2 3 3
250–300 19 0 0 1 9 9
VII (++) 0 9 9
(+) 1 0 0
Note. (+), Light labeling consisted of ≤9 labeled cells per embryo: (++), heavy labeling
consisted of ≥10 labeled cell embryo.
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Shh and Gsc expression in 0s stage rat embryos was relatively same to
those in mouse embryos (data not shown). Almost all embryos with
an excised PrCP cell layer developed mild to severe HPE (n=18),
whereas the control embryos developed normally (Figs. 1E–G). 8/18
(44.4%) embryos showed the fused nasal placode and the distal
midline loss of mandibular process (Fig. 1F). 9/18 (50%) embryos
showed more severe phenotype, such as one nasal placode, single
mandibular process and closed mouth (Fig. 1G). We also examined
the expression of Shh and Nkx2.1 gene in the rat embryos with or
without removal of PrCP cells. No Shh expression was detected both
in the basal telencephalon and hypothalamus in the embryos with
removal of PrCP cells, while midline Shh expression from the
midbrain to the spinal cord was not affected (Fig. 1J). Consistent
with the impaired Shh expression in the basal telencephalon, Nkx2.1
expression has completely disappeared from the telencephalon and
hypothalamus of the rat embryos with removal of PrCP (Figs. 1K, L).
Signiﬁcantly, the most severe HPE phenotype caused by removal of
PrCP cells was similar to the phenotype of mouse Shh−/− embryos
(Figs. 1G, H). These observations indicate that mammalian PrCP cells
are essential for the midline speciﬁcation of telencephalon, hypotha-
lamus and facial structures as observed in amphibian and chick
embryos.
Mouse PrCP cells develop into foregut endoderm, oral endoderm and
ventral cranial mesoderm
To determine the developmental fate of mammalian PrCP cells,
we examined cell lineages of rat and mouse PrCP cells from 0s stage
embryos. Firstly we labeled axial mesendoderm of rat embryos with
ﬂuorescent DiI at 0s stage (E9.5) and cultured these embryos for
60 h to assess the contribution of labeled PrCP cells to the brain and
craniofacial structures (Figs. 2A, B). We showed that the develop-
ment of anterior axial mesendoderm into the ventral cranial
mesoderm beneath the diencephalon, while the posterior axial
mesendoderm develop into notochord (Figs. 2A, B). Most of the
labeled anterior mesendoderm cells (Fig. 2A, bracket in the left
panel) developed into the ventral cranial mesoderm beneath the
diencephalon (Fig. 2A, arrows in the right panel), while some of DiI
labeled cells also developed into the mesoderm beneath the
midbrain (Fig. 2A). Posterior axial mesendoderm (Fig. 2B, bracket
in the left panel) developed into the notochord (Fig. 2B, arrows in
the right panel). No labeled posterior cells developed into the
ventral cranial mesoderm beneath the diencephalon (Fig. 2B, right
panel). These observations indicate the distinct developmental fate
between anterior and posterior axial mesendoderm at 0s stage, and
suggest the difference in the developmental fate between PrCP and
notochordal plate.
Since there is no visible boundary between PrCP and notochor-
dal plate on the axial mesendoderm, we traced the development of
PrCP cells by focally labeling the cells along the anterior–posterior
axis of the PrCP with ﬂuorescent DiI or DiO in 0s mouse embryos
(Fig. 2C). Gsc expressed region corresponds to our labeled domain
II–V, which is beneath the neuroepithelium developing into the
forebrain marked by Six3 and Hesx1 expression (Fig. S1). PrCP is
supposed to develop into ventral foregut endoderm, oral endoderm
and ventral cranial mesoderm, while notochordal plate develop into
notochord and dorsal foregut endoderm according to the chick/
quail chimera experiments (Couly et al., 1992). Ventral cranial
mesoderm means facial and cephalic mesoderm, which is com-
posed of paraxial mesoderm, prechordal mesoderm and mesoderm
derived from neural crest cells (Couly et al., 1992). The mouse
embryos with labeled PrCP cells were cultured for 24 h to assess the
contribution of labeled PrCP cells to the brain and craniofacial
structures (Fig. 2C). Cells in the anterior section of the PrCP (domains
I–IV in Fig. 2C) contribute to heart primordium (Fig. 2C, II-c), oralendoderm (Fig. 2C, IV-c) and midline ventral foregut endoderm
(Fig. 2C, I-c, II-c, IV-c, Table 1). Labeled cells from domain III–V of
the PrCP develop into the midline of oral endoderm (data not shown)
and ventral cranial mesoderm cells surrounding the ventral forebrain/
midbrain vesicle (Fig. 2C, V-c, Table 1). These observations suggest the
ventral cranial mesoderm derived from domain III–V contain
prechordal mesoderm in mammalian embryos (Aasar, 1931; Meier
and Tam, 1982; Sulik and Johnston, 1982; Sulik et al., 1994; Viebahn,
1995, 1999; Müller and O'Rahilly, 2003).
To characterize the labeled ventral cranial mesoderm cells derived
from domain IV and V, we checked if DiI-positive cells are expressing
SHH or NKX2.1 protein (Figs. 2D–G). SHH is a marker for the
notochord, ventral midline of CNS, and foregut endoderm. NKX2.1 is
a marker for the foregut endoderm and presumptive hypothalamus in
the diencephalon. We observed that DiI-positive cells from domain IV
do not develop into notochord (Fig. 2E-1, E-2), but develop into the
ventral cranial mesoderm beneath the diencephalons and ventral
foregut endoderm (Fig. 2D-1, 2, 3, E-1, 2, 3, arrows). On the other hand,
those fromdomain V develop into the notochord (Fig. 2F-2, G-2, arrow
head) and the ventral cranial mesoderm beneath the diencephalons
and ventral foregut endoderm (Figs. 2F-1, 2, 3, G-1, 2, 3, arrows). These
observations strongly suggest that some of the cells in domain IV and
V develop into the ventral cranial mesoderm beneath the diencepha-
lon, consistently with development of rat PrCP cells into the
mesoderm beneath the diencephalon (Fig. 2A). The boundary
between PrCP and notochordal plate may be in domain V, because
the labeled cells from this domain contributed to both ventral cranial
mesoderm and notochord.
Abnormal development of Shh mutant PrCP cells
The development of PrCP cells in Shh−/− embryos was investigated
to ascertain if impaired PrCP development underlies the HPE
phenotype. Since PrCP cells comprise the most anterior section of
the axial mesendoderm, we examined the formation and anterior
migration of axial mesendoderm in Shh−/− embryos. Axial mesendo-
derm cells can be distinguished from endoderm cells by their small
size and the presence of mono cilia on the cell surface, morphological
111K. Aoto et al. / Developmental Biology 327 (2009) 106–120features similar to those typical of nodal cells (Sulik and Johnston,
1982; Fig. 3A, a). We observed no signiﬁcant difference in the number
and morphology of axial mesendoderm cells in the node between
wild-type and Shh−/− embryos at E7.5 (Figs. 3A, a, B, b). Anterior
migration of the mutant axial mesendoderm cells was not affected
according to the number of the cells withmono cilia on the cell surface
(Figs. 3C, c, D, d). The marker genes expressing in the axial
mesendoderm such as FoxA2, T and Noggin in Shh−/− embryos
supported the normal anterior migration of the mutant axial
mesendoderm cells (Figs. 3E–L). In the mutant axial mesendoderm
cells abnormal Shh mRNA was detected in a similar pattern to wild-
type Shh expression, which is consistent with the normal anterior
migration of mutant axial mesendoderm cells (Figs. 3M, m, N, n). By
comparison, the expression of ptch1, a downstream gene activated by
Shh signal and monitored using Ptch1-lacZ, and Gsc mRNA was
completely abolished in Shh−/− mutant embryos (Figs. 3O, o, P, p, Q, R).
These results suggest that Shh signal is required for PrCP formation or
Gsc gene expression in PrCP cells. Since goosecoid-1mutant (Gsc-1−/−)
phenotype showing abnormal midline development, including fusion
and deletions in the midline of the chondrocranium (Belo et al., 1998)
is much milder than those in Shh mutants, the impaired Gsc gene
expression may be a part of abnormal PrCP development in Shh−/−
embryos (Fig. 3R). Our results indicate that some aspects of PrCP
development are impaired at the E7.75 (0 somite) stage of develop-
ment in Shh−/− embryos.Fig. 3. Anterior migration of the PrCP is unaffected, while Gsc expression is abolished, i
mesendoderm cells is observed between wild-type (A, a, C, c) and Shh−/− embryos at E7.
micrographs showing frontal views of wild-type (A, a, C, c) and Shh−/− (B, b, D, d) embryos at
epithelial cells by their smaller surface with single cilia (images of higher magniﬁcation are at
C, D) illustrate that no morphological difference in the axial mesendoderm is observed in th
indicated by red color (c, d). FoxA2 protein, T, Noggin and Shh mRNA is expressed in axial me
difference in the marker expression in the axial mesendoderm is observed in the mutants (F,
in Shh−/− embryos (N, n). Consistent with Shh expression, Ptch1 expression is localized in the
Gsc mRNA detected only in PrCP cells (black bracket in Q) is completely abolished in Shh−/−
indicates the position of coronal section shown in the panel (m–p). Scale bar, 200 μm.We then investigated the development of anterior axial mesendo-
derm cells in Shh−/− embryos by DiI labeling cultured whole embryos.
We labeled the wide area of mesendoderm, between domains I to VII
shown in Fig 2H, including the cell layers corresponding to the PrCP
cells in the wild-type, with DiI to monitor their development in Shh−/−
embryos. Mesoderm cells did not develop from the anterior
mesendoderm cells of Shh−/− embryos (Figs. 4D, F), whereas the
ventral cranial mesoderm cells developed normally from the PrCP
cells of wild-type embryos (Figs. 4C, E).
Excessive apoptosis occurs during development of the neural tube
and limb in Shh−/− mutant embryos (Borycki et al., 1999). For this
reason, it is possible that development of ventral cranial mesoderm
containing prechordal mesoderm is blocked by apoptosis in Shh−/−
embryos. We examined the distribution of apoptotic cells in mutant
and wild-type embryos during PrCP development (Figs. 4G–P). As
expected, we ﬁrst observed localized apoptosis only in the PrCP cell
layer at the 1–2s stage (Figs. 4J, L). In Shh−/− embryos, the localized
apoptosis of the PrCP layer became excessive at the 3s stage (E8.0)
(Figs. 4N, P, Fig. S1). The apoptosis in Shh−/− embryos was observed in
the identical domain to the Six3-expressing PrCP cells beneath the
Six3-expressing presumptive forebrain (Geng et al., 2008). By
comparison, there was no apoptosis of PrCP cells during PrCP
development in wild-type embryos (Figs. 4M, O). These results
suggest that impaired ventral cranial mesoderm formation in Shh−/−
embryos is due to excessive apoptosis of PrCP cells and that Shhn Shh−/− embryos. No signiﬁcant difference in the distribution and number of axial
5 and E7.75 (0s) stage (B, b, D, d). Embryos were monitored from scanning electron
E7.5 and E7.75 (0s) stage. Axial mesendoderm cells are distinguished from endodermal
the lower right of panel a, b, c and d). Highmagniﬁcations of the squares shown in (A, B,
e mutants (a, b, c, d). Distribution of axial mesendodermal cells in the domain I and II is
sendoderm cells, including PrCP cells (E, G, I, K, M, m). Consistent with SEM results, no
H, J, L). Weak expression of mutant ShhmRNA is also detected in the axial mesendoderm
axial mesendoderm, while the expression is not detected in the mutant midline (P, p).
embryos (R). Arrowhead in A–R indicates the position of node. Line in the panel (M–P)
Fig. 5. The role of Shh is involved in PrCP cell survival in a non-cell autonomous manner. Sagittal sections of chimeric embryos show the distribution of cells derived fromwild-type
and Shh−/− ES cells labeled with EGFP (green) at 1–2s and 3s stages. The thicker neuroepithelium (ne) and thinner PrCP cell layers are indicated (A, C). Only clustered Shh−/− cells
underwent apoptosis in the chimeras (arrows, B, D). Many apoptotic cells are detected in the chimeric embryos at the 3s stage (D), which is consistent with the timing of the onset of
apoptosis in the Shh−/− embryos (Fig. 4P). (E) Quantitative analyses of apoptosis among different sized cell clusters. Large mutant cell clusters have a high incidence of apoptotic
cells, while no apoptosis is detected in wild-type cells (indicated as n.d.). The number of the cluster examined for the apoptosis is indicated at the top of the bars. (F) Contribution of
ES-derived cells to the host tissues at E10.5. Wild-type ES cells contribute equally to wild-type tissue, while Shh−/− ES cells contribute to a lesser extent to the ventral forebrain (ventral
FB), head mesoderm (head) and foregut endoderm (foregut) (⁎Pb0.05, ⁎⁎Pb0.01). Scale bars, 50 μm.
Fig. 4. Abnormal PrCP development in Shh−/− embryos. (A, B) Sagittal views of whole-mount mouse embryos showing the distribution of the cells derived from PrCP cells after whole
embryo culture from the 0s to 12s stage. We labeled the wide area of PrCP cells, including the domain I–VII shown in Fig. 2F, with DiI at the 0s stage. Lines in the panels (A, B) indicate
the positions of the sections shown in the panels (C–F). Frontal sections showing the distribution of DiI positive PrCP-derived cells (orange) in control (C, E) and Shh−/− embryos (D, F)
(dorsal is to the top). Manymesodermal cells labeled with DiI are observed in the headmesoderm of thewild-type embryos (C, E), while there is no DiI-labeled headmesodermal cell
detected in mutant embryos (D, F). Anti-ssDNA-immunostaining (pink) shows apoptotic cells in coronal (G–L) and sagittal (M–P) sections of wild-type and Shh−/− embryos at the 0s
(G, H), 1–2s (I–L), and 3s (M–P) stages. The thicker neuroepithelium (ne) and thinner PrCP cell layers are indicated (G, H, K, L, O, P). (J, L) Apoptosis of PrCP cells is ﬁrst detected at the
1–2s stage in Shh−/− embryos. Apoptosis becomes excessive at the 3s stage in mutant PrCP cells (arrow heads in N, P). High magniﬁcations of the squares shown in (I, J, M, N) illustrate
that apoptosis localized only in mutant PrCP cell layers (K, L, O, P). Scale bar, 100 μm (A, B, I, J), 50 μm (G, H, K–P).
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113K. Aoto et al. / Developmental Biology 327 (2009) 106–120protein expression is directly or indirectly required for the main-
tenance of PrCP cell survival around the 0–3s stage. Together with the
lesion experiments, our results suggest that mutation of Shh impairs
the development of PrCP cells into ventral cranial mesoderm resulting
in HPE.
Shh is required for survival of PrCP cells in a non-cell autonomous manner
To determine whether Shh is required for the survival of PrCP
cells in a cell autonomous or non-cell autonomous manner, we
examined chimeric embryos composed of wild-type and Shh−/− cells.
We established Shh−/− ES cell lines carrying a green ﬂuorescent
protein (EGFP) reporter allele (B5/EGFP; Hadjantonakis et al., 1998),
and assessed apoptosis and the contribution of Shh−/− cells to the
chimeras at the 1∼2, 3s (Figs. 5A–D) and E10.5 stage. Although Shh−/−
cells comprised more than 60% of the cells in the chimeras, we
detected few apoptotic PrCP cells in chimeric embryos at the 0s and
1s stages (Figs. 5A, B, and data not shown). Consistent with the
timing of excessive apoptosis of PrCP cells in Shh−/− embryos at the 3s
stage (E8.0) (Fig. 4P), apoptosis was observed in chimeric embryos at
the 3s stage within the cluster of Shh−/− cells (Fig. 5D). The Shh−/−
cells in direct contact with wild-type cells did not undergo apoptosis
(Fig. 5E). This ﬁnding suggests that the survival of Shh−/− cells is
supported by Shh protein produced by the surrounding wild-type
cells. Apoptosis of PrCP cells is detected within the large mutant cell
cluster thereby suggesting that Shh signal is unable to reach these
cells (Fig. 5E). Consistently, the contribution of the Shh−/− cells at
E10.5 to the ventral forebrain, foregut endoderm and head mesoderm
was less than that of the wild-type cells (Fig. 5F). The contribution of
mutant cells was signiﬁcantly lower to the head mesoderm and
foregut endoderm than to other tissues (Fig. 5F), suggesting that
apoptosis of mutant PrCP cells is responsible for the low contribution
of Shh null cells in these tissues. Further analyses are necessary to
determine whether Shh protein itself plays as a survival factor forFig. 6. Excessive apoptosis of mutant PrCP cells is not rescued in Gli3;Shh double mutants. An
I) sections of wild-type (A, D, G), Shh−/− (B, E, H) and Shh−/−;Gli3−/− embryos (C, F, I) at E8.0 (A
layers are indicated (A–C). Excessive apoptosis of Shh−/− PrCP cells is not rescued in Shh−/−;Gli3
in the mandibular (md) in Shh−/− embryos (E, H) is signiﬁcantly reduced in Shh−/−;Gli3−/− mut
200 μm.mutant PrCP cells or other factors maintain the mutant cells' survival
in these chimeric embryos.
Apoptosis of PrCP cells in Shh−/− embryos is independent of Gli3 function
We used the Shh;Gli3 double mutant background to investigate if
Shh signal is directly required for PrCP cell survival. The transcription
factor Gli3, a potent antagonist of Shh signaling, induces apoptosis in
the telencephalon, spinal cord and limb bud of Shh−/− embryos
(Litingtung and Chiang, 2000; Litingtung et al., 2002; Aoto et al., 2002;
Rallu et al., 2002; te Welscher et al., 2002). We examined apoptosis of
PrCP cells in Shh−/−;Gli3−/− embryos to determine if Gli3 is involved in
the onset of apoptosis during mutant PrCP development. Consistent
with our ﬁndings in Shh−/− embryos (Fig. 6B), we observed excessive
apoptosis restricted to the PrCP cell layer in Shh−/−;Gli3−/− embryos at
the 3s stage (E8.0) (Fig. 6C). This ﬁnding suggests that apoptosis of
mutant PrCP cells is independent of Gli3 repressor function. In
contrast, apoptosis detected in the brain and facial primordia of Shh−/−
embryos at E9.0 and E10.5 (Figs. 6E, H) was rescued in Shh−/−;Gli3−/−
embryos, except for the midline of the brain and cranial mesoderm
(Figs. 6F, I).
We observed missing midline structures and rescued brain, facial
primordia and oral structures in late-stage Shh−/−;Gli3−/− embryos. This
ﬁnding is consistent with the localization of apoptosis to PrCP cells in
Shh−/−;Gli3−/− embryos (Figs. 6C, 7C, F, I, L, O, R). The midline cells of the
hypothalamus and optic chiasm of the forebrain did not develop in
Shh−/−;Gli3−/− embryos (Figs. 7C, F). This ﬁnding suggests a critical role
for Shh signal in brain development. Nkx2.1 expression was not
detected in the hypothalamus but was rescued in the medial
ganglionic eminence (Fig. 7C). The optic chiasm did not develop in
Shh−/−;Gli3−/− embryos and resulted in rescued fused optic stalk cells
(Fig. 7F). Together, these results suggest that the Shh signal released
from the PrCP is directly required for development of the hypotha-
lamus and optic chiasm. These ﬁndings are consistent with theti-ssDNA-immunostaining (pink) shows apoptotic cells in sagittal (A–F) and coronal (G–
–C), E9.5 (D–F) and E10.5 (G–I). The thicker neuroepithelium (ne) and thinner PrCP cell
−/−mutants, while apoptosis in the forebrain (fb), midbrain (mb) andmesenchymal cells
ants (F, I). Most double mutant embryos show the exencephaly phenotype (I). Scale bar,
Fig. 7. Shh is essential for the midline development of brain, face and oral structures
(A–R). In situ hybridization of whole-mount E10.5 mouse embryos reveals Nkx2.1 (A–C),
Pax2 (D–F), Pax9 (G–I), Pax7 (J–L) and Fgf8 (M–R) mRNA in wild-type, Shh−/− and Shh−/−;
Gli3−/− embryos. Lateral (A–C) and frontal (D–F) views of dissected brain vesicle show
Nkx2.1 and Pax2 expression, respectively. Dotted line outlines the optic ﬁeld (A–F).
(G–L) Frontal views of the face showing Pax9 and Pax7 expression, respectively. Dotted
line outlines the nasal pit (G–I). Panels in (M–R) represent top and bottom views of the
upper and lower jaw of the E10 embryos showing Fgf8 expression, respectively (frontal
is to the top). Nkx2.1 is expressed in the medial ganglionic eminence (arrow in A) and
hypothalamus (arrow head in A). Both areas of Nkx2.1 expression are abolished in Shh−/−
embryos (B). Nkx2.1 expression only in the medial ganglionic eminence is rescued in
Shh−/−;Gli3−/− embryos (arrow in C). Pax2 expression in the optic stalk (arrows in D), is
abolished in Shh−/− embryos (E), and rescued in the middle of the face of Shh−/−;Gli3−/−
embryos (arrow in F). The optic chiasm (redarrowhead inD) is not rescued in Shh−/−;Gli3−/−
embryos (F). Pax9 expression in themedial nasal process (arrows in G), which is abolished
in Shh−/− embryos (H), is rescued in themiddle of the face of Shh−/−;Gli3−/− embryos (arrows
in I). The lateral nasal process is relatively normal in Shh−/− embryos (arrow in J–L). Fgf8
expression domains in the maxillar and mandibular processes (arrows inM, P), which are
abolished in Shh−/− embryos (N, Q), are rescued in the middle of the face of Shh−/−;Gli3−/−
embryos (arrow in O, R). Scale bar, 200 μm.
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secreted from the prechordal mesoderm (Dale et al., 1997).
Consistent with the missing midline of the brain, the middle of
facial and oral structures was missing, and many of the facial
primordia, were rescued in Shh−/−;Gli3−/− embryos (Figs. 7I, L, O, R).
The midline of the upper jaw was missing and facial mesenchymal
cells in the medial nasal process, marked by expression of Pax9, wererescued in Shh−/−;Gli3−/− embryos (Fig. 7I). The absent midline of the
upper and lower jaw results in the fusion of Fgf8 expression domains
in the maxillar and mandibular process (arrows in Figs. 7O, R). This
ﬁnding indicates that Shh signal is directly required for development
of midline tissue and is consistent with the development of the mouse
PrCP cells into the midline of foregut endoderm shown by DiI labeling
(Fig. 2C). The apoptosis of PrCP cells in Shh−/−;Gli3−/− embryos (Fig. 6C)
may underlie the midline defects shown in Fig. 7.
The apoptosis of PrCP cells at E8.0 in Shh−/−;Gli3−/− embryos may
induce the onset of missing midline tissues in the double mutants. For
this reason, organogenesis and skeletal development in Shh−/−;Gli3−/−
embryos was examined to determine the developmental outcome of
missing midline cells. Midline oral tissue, including the upper and
lower incisor teeth, tongue, and submandibular gland, did not develop
in Shh−/−;Gli3−/− embryos (Fig. 8C, F, I, data not shown). In addition, the
neural component of the pituitary gland, Rathke's pouch, temporal
bones, and extrinsic ocular muscle, did not develop in Shh−/−;Gli3−/−
embryos (data not shown). Skeletal elements of midline strictures,
including the palatal process of the maxillar and premaxillar bones,
and the palatal, pterygoid, basisphenoid and basioccipital bones, were
not rescued in Shh−/−;Gli3−/− embryos (Figs. 8L, O). Meckel's cartilage
was rescued but fused in the center, which is consistent with the
rescued mandibular process and the absence of midline structures in
the double mutants (Figs. 7R, 8Q). These observations suggest that
Shh signal is directly required for the formation of midline tissues
during brain and craniofacial development. The apoptosis of PrCP
cells in Shh−/−;Gli3−/− embryos at E8.0 (Fig. 6C) may induce the onset
of midline speciﬁc abnormalities.
Apart from midline tissues, the development of many brain and
craniofacial structures was rescued in Shh−/−;Gli3−/− embryos. The
rescued skeletal elements indicate that facial mesenchymal cells
derived from neural crest can survive in the absence of Shh signal if
Gli3 is simultaneously absent.
Fate mapping of HH-responding cells in developing brain and
craniofacial tissues
The above ﬁndings lead us to investigate the cell lineages
responding to the HH signal released from the PrCP cells or prechordal
mesoderm cells during midline development. The cell lineages
responding to HH signals from the PrCP or prechordal mesoderm
cells were followed using an inducible genetic labeling system (Fig. 9A).
A unique HH-responding tissue lineage analysis system was devel-
oped by knock-in a tamoxifen-inducible Cre recombinase to the Gli1
locus (Gli1-CreERT2) (Li et al., 2000; Ahn and Joyner, 2004). This system
takes advantage of the regulation of the Gli1 locus by HH signaling. In
the present study we labeled the early-onset of HH-responding cells
during PrCP development using tamoxifen to induce Cre at E8.5
(expressed from the Gli1-CreERT2 allele), then assayed LacZ activity
from the Rosa26 Cre reporter (Soriano, 1999, Ahn and Joyner, 2004,
2005; Haraguchi et al., 2007) at E14.5 (Fig. 9A). Since Gli1 is also
expressed in PrCP cells at E8.5 during head process and craniofacial
development (Bai et al., 2002), the early-onset of HH-responding may
contain the cells derived from PrCP cells. We also examined the
contribution of late-onset (E9.5 and 11.5) HH-responsive cells to the
midline tissue to monitor late-stage Shh target cells (Figs. S3, S5, S6).
Under these temporal conditions, we detected signiﬁcant LacZ
staining in the tissues of the brain (Figs. 9B, C), mesodermal cells
(Figs. 9D–G) and derivatives of foregut endoderm (Figs. 9H–L).
Analysis of LacZ activity at E14.5 revealed that early-onset (E8.5) and
long-contributing HH-responding cell lineages develop into midline
structures (Figs. 9B–L). In the brain, we detected LacZ staining in the
ventral hypothalamus (Fig. 9B), pons (data not shown), and neural
component of the pituitary (Fig. 9C). These ﬁndings indicate that
commitment of ventral cell types by HH signaling occurs at E8.5
(Figs. 9B, C, data not shown). No late-onset (E9.5 and 11.5) HH-
Fig. 8.Missing midline of face and oral structures is not rescued in Shh−/−;Gli3−/− mutants. Frontal sections of E14.5 mouse embryos of wild-type (A, D, G), Shh−/− (B, E, H), and Shh−/−;
Gli3−/− embryos (C, F, I). All sections are stained with HE. Apart from the tongue (t), palatal shelf (ps), and upper and lower incisor tooth buds (it), the craniofacial tissues missing in
Shh−/− embryos (B, E, H) are rescued in Shh−/−;Gli3−/− embryos (C, F, I). Consistent with the restoration of craniofacial mesenchymal tissues at E14.5, craniofacial skeletal
development is also rescued in Shh−/−;Gli3−/− embryos at E18.5. Most parts of the skull are missing in Shh−/− embryos (K, N). Many skeletal elements derived from neural crest cells,
including the premaxilla (pm), maxilla (mx), arytenoid cartilage (ac) and Meckel's cartilage (mc) are rescued in Shh−/−;Gli3−/− embryos (L, O, Q). Diagram of skeletal element
specimens (M, N, O); yellow indicates rescued bone while red indicates those elements not rescued (N, O). ac, arytenoid cartilage; bb, basioccipital bone; bs, basisphenoid; cc,
cupola cochlearis; e, eye; fv, follicles vibrissa; it, incisor tooth; li, lower incisor; mc, Meckel's cartilage; mt, molar tooth; mx, maxilla; nc, nasal capsule; ns, nasal septum; pl, palatal;
pm, premaxilla; ppmx, palatal process of maxilla; pppx, palatal process of premaxilla; ps, palatal shelf; pt, pterygoid; t, tongue; tg, trigeminal ganglion; ty, tympanic ring; ui, upper
incisor; vo, vomeronasal organ. Scale bar, 1 mm.
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pons, or neural component of the pituitary (Figs. S3B–E). These
ﬁndings were consistent with the down-regulation of both SHH
protein and Gli1 expression in the ventral midline of diencephalon at
E9.5 and E11.5 (Fig. S4, Rallu et al., 2002; Furimsky and Wallace,
2006). Thus, our observations suggest that induction of ventral
forebrain by Shh protein secreted by mouse PrCP or prechordal
mesoderm cells occurs at E8.5.
With respect to the development of mesenchymal tissues, we
observed the contribution of early-onset (E8.5) HH-responding
lineages to the cartilage primordia of the basisphenoid and
basioccipital bones (Fig. 9D), the mesenchymal cells of the palatal
shelf (Fig. 9E), the extrinsic ocular muscle (Fig. 9F), and the primordia
of the temporal bone (Fig. 9G, Table 2). We also observed LacZ stained
early-onset (E8.5) HH-responding lineages in endodermal tissues,
including Rathke's pouch (Fig. 9C), upper and lower incisor teeth
(Figs. 9H, I), tongue (Fig. 9J), oral cavity (Fig. 9K), and submandibular
gland (Fig. 9L, Table 2). These ﬁndings strongly suggest that early-
onset (E8.5) HH-responding cell lineages contain PrCP derived cells,
because the origin of the basisphenoid, basioccipital bones and
extrinsic ocular muscle was identiﬁed as prechordal mesoderm using
quail-chick chimeras (Jacob et al., 1984; Wachtler et al., 1984; Noden,
1988; Couly et al., 1992).
The tissue containing late-onset (E9.5 or 11.5) HH-responding cell
lineages, including Meckel's cartilage (Figs. S3J, K), molar teeth (Figs.
S5H, J), follicle vibrissa (Fig. S5L), retina (Fig. S6E) and cochlea (Fig.
S6H) could develop without Shh signal in Gli3;Shh double mutant
embryos (Figs. 8C, F, I, L, Q, Table 2). Since the rescued molar teeth,follicle vibrissa and Meckel's cartilage showed smaller in size and
disorganized morphology, the HH-signal in late-stage embryos may
be required for their development as the local organizing center.
Discussion
The functional importance of Shh signal is evident from the HPE
phenotype reported in human and mouse mutants (Chiang et al.,
1996; Belloni et al., 1996; Roessler et al., 1996). In the present study,
we investigated unanswered questions on the role of mammalian
PrCP in mammalian brain and craniofacial development to further
understand the developmental basis of HPE pathogenesis. Our
ﬁndings show that mouse PrCP cells develop into the midline of
foregut endoderm and ventral cranial mesodermal cells from E7.75 to
E8.75 as an essential process in the development of midline
structures, because prechordal mesoderm is a part of ventral cranial
mesoderm (Figs. 1, 2, 10). We also provide evidence that mouse Shh
protein expression in PrCP is directly or indirectly required for
ensuring PrCP cell survival at E8.0 of mouse embryogenesis (Figs. 4–8
and Table 2). The HH signal at E8.5 (9s) is responsible for commitment
of the midline of neural, endodermal and mesodermal tissue, such as
ventral hypothalamus, pons, pituitary gland, incisors, tongue, foregut
endoderm, submandibular gland, extrinsic ocular muscle, and
cartilage primordia of the basisphenoid bone and temporal bones
(Figs. 9, S3–6 and Table 2). Thus, we reveal the critical role of
mammalian PrCP cells in the origin of midline cells and as a center
controlling surrounding tissue during brain and craniofacial devel-
opment. These ﬁndings contribute to our understanding of the
Fig. 9. Contribution of early-onset (E8.5) HH-responding cells to the brain and craniofacial structures. (A) Schematic diagram depicting the inducible Gli1-CreERT2 allele and the
experimental time course employed to label HH-responding tissues. The action of HH during brain and craniofacial development is examined at three different time points, E8.5, 9.5
and 11.5, and the contribution of HH-responding cells is compared with E14.5. The results by tamoxifen administration at 9.5 and 11.5 are shown as Supplementary materials. (B–Q)
LacZ staining of brain (B, C), mesodermal tissue (D–G), oral tissue in the medial region (H–L) and oral and facial tissues in the lateral region (M–Q) in Gli1-CreERT2;R26R embryos
administered with tamoxifen at E8.5. Coronal sections through the brain show the contribution of HH-responding cells (LacZ-positive cells) to the hypothalamus (B) and neural
component of the pituitary (p in C). The contribution of HH-responding cells to the hypothalamus and neural component of the pituitary (p) is detected only at E8.5 (B, C). The
contribution of HH-responding cells to Rathke's pouch (rp) is also prominent (C). Contribution of HH-responding cells to the craniofacial mesenchymal tissues is also observed (D–G).
Coronal sections through craniofacial tissues show the contribution of HH-responsive mesenchymal cells to the basisphenoid bone (bb) (D), palatal shelf (ps) (arrowheads in E),
extrinsic ocular muscle (eom) (arrowheads in F), and temporal bone (tb) (arrowheads in G). The early-onset HH-responsive cells are also observed in the epithelial cells of incisors
(arrow heads in H, I), oral cavity (arrow heads in K), and submandibular gland (arrow heads in L). In the tongue (t), the HH-responsive cells contribute to both epithelial (arrowheads
in J) and mesenchymal cells (arrow in J). There is almost no contribution of early-onset (E8.5) HH-responding cells in facial and oral tissues in the lateral region such as upper and
lower molar (um and lm) (M, N), follicle vibrissa (O), vomeronasal organ (vo) (P) and nasal capsule (nc) (Q).
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direct evidence of the developmental basis of this disease.
Shh is required for the maintenance of survival of mouse PrCP cells,
ventral forebrain, and facial mesenchymal cells
The HPE phenotype suggests a crucial function for Shh signal in the
induction of midline tissue during mammalian brain and facial
development (Echelard et al., 1993; Marti et al., 1995; Porter et al.,
1995; Roelink et al., 1995; Chiang et al., 1996). Shh signaling is also
required for the survival of facial mesenchymal cells derived from
cranial neural crest cells (Ahlgren and Bronner-Fraser, 1999; Brito et
al., 2006). In the present study, we provide evidence that Shh plays
two important roles; one in the maintenance of PrCP cell survival and
the other in the maintenance of surrounding cells in a paracrine
manner. We show that Shh signal is required for the maintenance of
PrCP cell survival at the 1–3 somite stage (Figs. 4, 5). Our results
suggest that Shh signal is required for the survival of Shh-expressing
axial mesendoderm cells; not only for the development of PrCP cells
but also for development of the notochord and foregut endodermal
cells. The premise that Shh protein also has a direct survival function
in the notochord, where it acts in an autocrine manner, is consistent
with the observation that Shh−/− embryos show progressive anterior-
to-posterior loss of notochord tissue concomitant with loss ofBrachury expression between E7.5 and E 9.5 (Chiang et al., 1996). In
Shh−/− embryos, anterior foregut endoderm, which expresses Shh
throughout development, also shows progressive apoptosis resulting
in tracheal esophageal ﬁstula and esophageal atresia (Litingtung et al.,
1998). The observed apoptosis in Shh−/− embryos suggests that Shh
protein is required for the maintenance of Shh-expressing cells
including those comprising the PrCP, notochord, and foregut endo-
derm, in an autocrine manner. Further studies are necessary to fully
understand the molecular mechanisms underlying the requirement of
Shh signal in the survival of Shh-expressing cells.
Shh signal also functions to maintain the survival of cells in the
medial ganglionic eminence and facial mesenchyme cells derived
from neural crest, in a paracrine manner (Figs. 6–8). Genetic analyses
reveal that the molecular mechanism underlying the maintenance of
cell survival by Shh signaling involves the suppression of Gli3 activity.
Gli3, a potent Shh antagonist, induces cell cycle arrest and apoptosis in
the brain and spinal cord of Shh−/− embryos (Cayuso et al., 2006). This
is consistent with the ﬁnding that apoptosis observed in Shh−/−
embryos is rescued in Shh−/−;Gli3−/− embryos (Litingtung and Chiang,
2000; Litingtung et al., 2002; Aoto et al., 2002; Rallu et al., 2002; te
Welscher et al., 2002). Furthermore, the dominant inhibitory Gli
protein, Gli3R, induces apoptosis via cell cycle arrest in the developing
spinal cord (Cayuso et al., 2006). The survival of neural crest cells
during craniofacial development requires Smo activity (Jeong et al.,
Table 2
Mutant phenotype of Shh−/− and Gli3−/−;shh−/− mutants and onset stages of HH-responding lineages during brain craniofacial development
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protein secreted from PrCP cells in the survival of forebrain and neural
crest cells is a process mediated by Smo. Shh signal also controls
migration and cell adhesion of neural crest cells independent of the
Ptch1–Smo–Gli signaling pathway (Testaz et al., 2001). Further
analyses are necessary to understand how the gradient of diffused
Shh protein released from prechordal mesoderm cells modulates the
proliferation and cell fate determination of these cells during
forebrain and craniofacial development.
Pathogenesis of human HPE due to mutations in the Shh gene
It is unknown why human patients with heterozygous SHH
mutations display a high level of intrafamilial phenotype variability
in HPE pathogenesis. In humans, intrafamilial phenotype variability,
ranges from severe cyclopia to very mild clinical signs of HPE
including fused upper incisors and clinically normal individuals
(Muenke et al., 1994; Belloni et al., 1996; Roessler et al., 1996; Hehret al., 2004). In drastic contrast, only Shh homozygous mouse embryos
display the HPEmutant phenotypewithout phenotypic variability and
heterozygous Shhmouse mutants appear normal (Chiang et al., 1996).
Our ﬁnding that Shh is required for the survival of PrCP cells
provides a developmental mechanism to explain the pathogenesis of
HPE. In this study we provided evidence that Shh signal ensures the
maintenance of viable PrCP cells during formation of ventral cranial
mesoderm. This ﬁnding suggests that the level of SHH protein
expressed from one copy of the SHH gene is not sufﬁcient to prevent
apoptosis of midline cells caused by other factors during human
development. The apoptosis of PrCP appears to be critical for the onset
of HPE as essential signalingmolecules, including Chordin, Noggin and
Dkk-1, which are expressed in PrCP cells (Anderson et al., 2002;
Mukhopadhyay et al., 2001; Lewis et al., 2007). Chordin and Noggin
are antagonists of BMP signaling and act upstream in the signal
transduction pathway. The simultaneous absence of Chordin and
Noggin leads to a wide variety of HPE phenotypes (Anderson et al.,
2002). Dkk-1, a secreted protein antagonist of Wnt signaling, is also
Fig. 10. Summary of mouse PrCP and neural epithelium development at different stages shown by SEM of embryos sectioned sagittally. High magniﬁcations of the squares shown in
(A–D) indicate that the cell layer contains PrCP cells and neuroepithelium (a–d). Magenta represents endoderm cells including PrCP cells (prcp) and their derivatives, while green
represents neural epithelium (ne) (a–d). The 3s is the stage of apoptosis that becomes excessive inmutant PrCP cells (B, b). Ventral cranialmesoderm develops from PrCP between the
3s and 9s stage (B, b, C, c). Epithelial cells of oral cavity (oc), ventral cranial mesoderm (vcm) and dorsal foregut (df) and ventral foregut endoderm (vf) contain the cells derived from
PrCP cells (D, d). Scale bars, 50 μm.
118 K. Aoto et al. / Developmental Biology 327 (2009) 106–120required for head development in the mouse (Mukhopadhyay et al.,
2001; Lewis et al., 2007). Mutations in the human DKK-1 gene are
thought to be responsible for familial HPE (Roessler et al., 2000). It is
possible that mutations in the Shh gene make the PrCP cells unstable
and sensitive to other risk factors, thereby inducing apoptosis and
leading to an overall reduction in levels of Chordin, Noggin and Dkk-1.
This may explain why mutations in the SHH gene are the most
common genetic cause of human HPE identiﬁed to date (Nanni et al.,
1999).
Combination of human SHH mutation and environmental risk
factors may cause a wide variety of HPE phenotypes among
heterozygous SHH patients. Oxidative stress may potentially impair
Shh protein expression during midline speciﬁcation because fetal
alcohol exposure and maternal diabetes—two major environmental
causes of HPE—are known to increase reactive oxygen species during
pregnancy in humans and mice (Sulik et al., 1981; Webster et al.,
1983; Cohen and Shiota 2002). We recently reported that transient
ethanol exposure at E7–7.25 reduces Shh protein expression by
activating PKA in the anterior PrCP and inducing excessive apoptosis
(Aoto et al., 2008). These observations suggest that oxidative stress-
induced reduction of Shh protein expression is critical for the onset of
PrCP cell apoptosis. The high variability in intrafamilial HPE
phenotypes among heterozygous SHH patients may result from
variations in the number of surviving PrCP cells following exposure
to environmental factors during pregnancy. The avoidance of
environmental factors that damage Shh expression during pregnancy
may protect PrCP cells and minimize the risk of severe HPE in
heterozygous SHH cases.
Understanding the precise physiological role of Shh signal during
normal development, and the mechanisms of action of genetic and
environmental factors, is necessary for the implementation of
preventive measured to protect the developing fetal brain. Further
investigations will enhance our understanding of the molecular
mechanisms underlying human birth defects caused by genetic and
environmental factors that interfere with Shh signaling.
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